about
Androgens (dehydroepiandrosterone or testosterone) for women undergoing assisted reproductionRole of androgens, progestins and tibolone in the treatment of menopausal symptoms: a review of the clinical evidenceManagement of Menopausal Symptoms.The Female Sexual Response: Current Models, Neurobiological Underpinnings and Agents Currently Approved or Under Investigation for the Treatment of Hypoactive Sexual Desire Disorder.Systemic delivery of estradiol, but not testosterone or progesterone, alters very low density lipoprotein-triglyceride kinetics in postmenopausal women.Counseling postmenopausal women about bioidentical hormones: ten discussion points for practicing physicians.Management of hypoactive sexual desire disorder in women: current and emerging therapiesSex differences in lipid and lipoprotein metabolism: it's not just about sex hormones.Benefits and risks of testosterone treatment for hypoactive sexual desire disorder in women: a critical review of studies published in the decades preceding and succeeding the advent of phosphodiesterase type 5 inhibitors.The association between hyperandrogenemia and the metabolic syndrome in morbidly obese women.Effectiveness of a low dose testosterone undecanoate to improve sexual function in postmenopausal women.Sexual function in young women with spontaneous 46,XX primary ovarian insufficiency.Mammary gland and endometrial effects of testosterone in combination with oral estradiol and progesteroneTestosterone and libido in surgically and naturally menopausal women.Androgens in women before and after the menopause and post bilateral oophorectomy: clinical effects and indications for testosterone therapy.Role of hormones in hypoactive sexual desire disorder and current treatment.Recommendations and Choices for BRCA Mutation Carriers at Risk for Ovarian Cancer: A Complicated Decision.Intrinsic links among sex, emotion, and reproduction.
P2860
Q24187619-A075B5DE-5615-4EE0-A813-B3C7D020E545Q24647700-3DF341D3-3CD4-4B51-85E6-EFDCA8CB24B2Q27318357-CA50ED5F-B41D-41FF-92B0-05637415A245Q30278438-0D14A95C-B453-45B7-9148-36CE066AF205Q33837130-9BCC392C-1839-453F-855B-63A0E3B9BBA5Q34169103-393E69E6-DFD8-44EF-A260-5D4011C2BC36Q34272161-AFC2F063-21E4-4012-8C1E-632DD7FC1BCEQ34758488-ED431AFA-7804-4DEF-9383-A5F6EA6EECCDQ35143192-B36F23B4-B430-497E-8CB0-B1183280A3FDQ35645927-F899870C-E29C-42E7-8742-45241A6B4F8AQ35859468-4F335FE2-57C3-40CA-8D67-AC2203D2656EQ36992650-C1B384A7-263D-400F-93A7-BC5A66B1E3ACQ37371417-C3DF84AA-95D4-4494-8DD4-60E6244DEB3AQ37608368-604BBE50-2DA1-4E5F-8654-05B18499D67FQ39592407-9BEF1E0C-7B65-4F04-A382-04D766EC85BCQ47560129-6AFFF061-A1F3-4BA5-94E5-C3CCF175AEBCQ54956851-9C02C7A7-8D29-40C9-B8F3-5276A2DFEF91Q55388869-8C8BF2C9-77A2-40D0-9368-D9E9159F9FED
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Testosterone for peri and postmenopausal women
@ast
Testosterone for peri and postmenopausal women
@en
Testosterone for peri and postmenopausal women
@en-gb
Testosterone for peri and postmenopausal women
@nl
type
label
Testosterone for peri and postmenopausal women
@ast
Testosterone for peri and postmenopausal women
@en
Testosterone for peri and postmenopausal women
@en-gb
Testosterone for peri and postmenopausal women
@nl
prefLabel
Testosterone for peri and postmenopausal women
@ast
Testosterone for peri and postmenopausal women
@en
Testosterone for peri and postmenopausal women
@en-gb
Testosterone for peri and postmenopausal women
@nl
P2093
P2860
P1476
Testosterone for peri and postmenopausal women
@en
P2093
Robin J Bell
Susan R Davis
Woraluk Somboonporn
P2860
P356
10.1002/14651858.CD004509.PUB2
P577
2005-10-19T00:00:00Z